Signant Health Upgrades Clinical Supplies Management Platform
GxP Inventory available in two options for varying sponsor and CRO requirements.
Signant Health has relaunched its Signant SmartSignals Supplies GxP Inventory, an upgrade to its SmartSignals Supplies software. It available as either an Essential or Enterprise option, both of which are SaaS-based, with decisions revolving around company and/or trial size.
The Essential option enables sponsors to use a pre-configured system for inventory manufacturing, management, and QA/QP release. The Enterprise option provides advanced features for larger customers with internal supply chain capabilities to meet individualized requirements, sponsor-specific terminology/labels, and additional workflow/process options.
Reference: Signant Health Extends the Power of Clinical Supply Management Software to the Small and Mid-Size Market Through Updated and Enhanced Supplies Platform, Philadelphia, PA, July 10, 2023.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
